Navigation Links
North Dakota Grants Enova Medical Technologies a $2.5 Million Centers of Excellence Grant

Enova Teams with North Dakota Universities to Develop a New Thrombectomy

Device to Remove Clots in Blood Vessels

ST. PAUL, Minn., Nov. 8 /PRNewswire/ -- In a unanimous decision on Oct. 29, North Dakota state lawmakers, with the support of Governor John Hoeven and the state's Centers of Excellence Commission, approved a $2.5 million grant for Enova Medical Technologies, the University of North Dakota (UND) and North Dakota State University (NDSU) to develop and manufacture an innovative thrombectomy device.

The grant will fund the Center of Excellence for Biomedical Device Research, Development and Commercialization, which will focus on Enova's patented license for a thrombectomy device that removes clots in blood vessels. Enova will team with researchers at the UND School of Engineering, the UND School of Medicine, and North Dakota State University College of Engineering to develop the device.

The company will also work directly with the Minot Area Development Corporation to establish manufacturing operations in Minot. Due to the high market potential for this device, Enova anticipates creating several hundred jobs in the Minot area over the next two to five years.

Fariborz Boor Boor, CEO of Enova, said the grant reflects the confidence the two major North Dakota research universities have shown in Enova's thrombectomy device, as well as the state's willingness to promote and fund cooperative efforts between businesses and its universities.

"This partnership between Enova, the state of North Dakota, UND and NDSU, complements our vision of developing a 'creative, collaborative community' and will help our collective desire to develop a thrombectomy catheter that removes blood clots from stroke patients," he said. "This collaboration will create a win-win-win situation; North Dakota wins, Enova wins, and most importantly, stroke patients will win."

The mission of the Center of Excellence for Biomedical Device Research, Development and Commercialization is to provide the research, development, and commercialization resources for a range of biomedical devices. Over time, the Center will conduct multiple, concurrent projects for various biomedical companies and cities, thereby providing the potential for economic development throughout North Dakota and the region.

Enova Medical Technologies, a privately-held company, is engaged in the development and commercialization of proprietary medical devices and is an experienced provider of product development, manufacturing, and commercialization services for the medical device industry. From Class I to Class III devices, Enova understands the technical challenges of product design, engineering, research and development, the regulatory steps required to successfully commercialize products, and the marketing and sales efforts needed to move inventory off the shelf. For more information, visit

SOURCE Enova Medical Technologies
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Novo Nordisk Appoints New Leader of North American Business
2. Health IT Event Draws Experts to the Pacific Northwest
3. Revolutionary HD Surgical Footage from North Shore-LIJ Surgeon to be Broadcast for the First Time on ABCs 20/20, National Geographic Channel
4. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
5. Evanston Northwestern Healthcare Wins Award For Patient Safety
6. Physician Team at Northwestern Memorial Performs Rare Oral Gallbladder Removal
7. Northstar Healthcare Announces Option to Purchase a 60% Interest in The Palladium for Surgery - Dallas
8. Dermatologists identify North Texas leishmaniasis outbreak
9. Radiation Therapy Services Acquires North Carolina Facility
10. Northern Michigan Regional Health System Named a Working Mother 100 Best Company - 2007 by Working Mother Magazine
11. NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(TM) in Territories Outside North America
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: